ArticleBMC medical imaging2025
Relationship between MRI features and HIF-1α, GLUT1 and Ki-67 expression in pituitary adenoma with cystic degeneration.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundPituitary adenomas (PAs) are prevalent tumors that often exhibit ischemia, hypoxia, and cystic transformations, impacting their prognosis. The relationship between cystic degeneration in PAs and the expressions of hypoxia-inducible factor-1α (HIF-1α), glucose transporter 1 (GLUT1), and Ki-67 remains unclear. This study aims to analyze the correlation between MRI characteristics of cystic PA and the expression of these proteins.
methodsThis is a retrospective analysis. A total of 74 patients with cystic PA and 30 PA patients without cystic degeneration were enrolled. Their MRI signs were analyzed. According to the T2WI signs of PA, they were divided into the fluid level group (n = 26), non-fluid level group (n = 48), and non-cyst group (n = 30). Immunohistochemistry was performed to evaluate the expression levels of HIF-lα, GLUT1, and Ki-67 protein. Univariate and multinomial logistic regression analyses were used to evaluate the factors affecting MRI signs of PA. Spearman correlation was also performed.
resultsThere was no significant difference in gender, age, and HIF-1α protein expression among the three groups. Significant differences were found in invasiveness (P = 0.008), GLUT1 (P < 0.001), and Ki-67 protein expression (P = 0.009) among the three groups. Pairwise comparisons revealed statistically significant differences in invasiveness, GLUT1, and Ki-67 protein expressions between the non-fluid level group and the non-cyst group. Furthermore, GLUT1 protein expression was significantly different between the non-fluid level group and the fluid level group. Notably, GLUT1 was identified as an independent factor for the non-fluid level cystic characteristics of PA. Additionally, GLUT1 was positively correlated with invasiveness and Ki-67.
conclusionThe non-fluid level cystic PA has higher invasiveness and higher proliferation than fluid level cystic PA and non-cyst PA, which may be related to high glucose metabolism as indicated by GLUT1 expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.